TGFB1 and type 2 diabetes mellitus: Elevated glucose levels in T2DM have been demonstrated to increase pro-inflammatory cytokines, such as TNF-α, IFN-γ, and TGF-β, which may augment TGF-β pathway activation and heighten the risk of LUAD [33].